Separation systems are used for the purification and separation of biological products such as biopharmaceuticals, biochemicals, and diagnostic reagents depending upon the electrostatic charge, density, diffusivity, shape, polarity, solubility, and volatility characteristics. The equipment used for the separation of biological material from complex mixture or solution includes chromatography, membranes or filters, and centrifuges.
The global market for Separation Systems for Commercial Biotechnology was estimated to be worth US$ 26530 million in 2023 and is forecast to a readjusted size of US$ 44140 million by 2030 with a CAGR of 7.5% during the forecast period 2024-2030
North American market for Separation Systems for Commercial Biotechnology was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Separation Systems for Commercial Biotechnology was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Separation Systems for Commercial Biotechnology was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Separation Systems for Commercial Biotechnology include Thermo Fisher Scientific, GE Healthcare, Agilent Technologies;Shimadzu Corporation, µþ¾±´Ç²Ñé°ù¾±±ð³Ü³æ, Bio-Rad Laboratories, Inc., Hitachi Koki, Merck &, Inc., QIAGEN and Waters Corp, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Separation Systems for Commercial Biotechnology, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Separation Systems for Commercial Biotechnology by region & country, by Type, and by Application.
The Separation Systems for Commercial Biotechnology market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Separation Systems for Commercial Biotechnology.
Market Segmentation
By Company
Thermo Fisher Scientific
GE Healthcare
Agilent Technologies;Shimadzu Corporation
µþ¾±´Ç²Ñé°ù¾±±ð³Ü³æ
Bio-Rad Laboratories, Inc.
Hitachi Koki
Merck &, Inc.
QIAGEN
Waters Corp
Sartorius
PerkinElmer, Inc.
Danaher
Miltenyi Biotec
BD
Segment by Type:
Microarray
Lab-on-a-chip
Biochip
Magnetic separation
Chromatography
Flow cytometry
Membrane filtration
Electrophoresis
Centrifugation
Others
Segment by Application
Pharmaceutical
Food & Cosmetics
Agriculture
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Separation Systems for Commercial Biotechnology manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Separation Systems for Commercial Biotechnology in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Separation Systems for Commercial Biotechnology in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Market Overview
1.1 Separation Systems for Commercial Biotechnology Product Introduction
1.2 Global Separation Systems for Commercial Biotechnology Market Size Forecast
1.2.1 Global Separation Systems for Commercial Biotechnology Sales Value (2019-2030)
1.2.2 Global Separation Systems for Commercial Biotechnology Sales Volume (2019-2030)
1.2.3 Global Separation Systems for Commercial Biotechnology Sales Price (2019-2030)
1.3 Separation Systems for Commercial Biotechnology Market Trends & Drivers
1.3.1 Separation Systems for Commercial Biotechnology Industry Trends
1.3.2 Separation Systems for Commercial Biotechnology Market Drivers & Opportunity
1.3.3 Separation Systems for Commercial Biotechnology Market Challenges
1.3.4 Separation Systems for Commercial Biotechnology Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Separation Systems for Commercial Biotechnology Players Revenue Ranking (2023)
2.2 Global Separation Systems for Commercial Biotechnology Revenue by Company (2019-2024)
2.3 Global Separation Systems for Commercial Biotechnology Players Sales Volume Ranking (2023)
2.4 Global Separation Systems for Commercial Biotechnology Sales Volume by Company Players (2019-2024)
2.5 Global Separation Systems for Commercial Biotechnology Average Price by Company (2019-2024)
2.6 Key Manufacturers Separation Systems for Commercial Biotechnology Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Separation Systems for Commercial Biotechnology Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Separation Systems for Commercial Biotechnology
2.9 Separation Systems for Commercial Biotechnology Market Competitive Analysis
2.9.1 Separation Systems for Commercial Biotechnology Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Separation Systems for Commercial Biotechnology Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Separation Systems for Commercial Biotechnology as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Microarray
3.1.2 Lab-on-a-chip
3.1.3 Biochip
3.1.4 Magnetic separation
3.1.5 Chromatography
3.1.6 Flow cytometry
3.1.7 Membrane filtration
3.1.8 Electrophoresis
3.1.9 Centrifugation
3.1.10 Others
3.2 Global Separation Systems for Commercial Biotechnology Sales Value by Type
3.2.1 Global Separation Systems for Commercial Biotechnology Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Separation Systems for Commercial Biotechnology Sales Value, by Type (2019-2030)
3.2.3 Global Separation Systems for Commercial Biotechnology Sales Value, by Type (%) (2019-2030)
3.3 Global Separation Systems for Commercial Biotechnology Sales Volume by Type
3.3.1 Global Separation Systems for Commercial Biotechnology Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Separation Systems for Commercial Biotechnology Sales Volume, by Type (2019-2030)
3.3.3 Global Separation Systems for Commercial Biotechnology Sales Volume, by Type (%) (2019-2030)
3.4 Global Separation Systems for Commercial Biotechnology Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Pharmaceutical
4.1.2 Food & Cosmetics
4.1.3 Agriculture
4.1.4 Others
4.2 Global Separation Systems for Commercial Biotechnology Sales Value by Application
4.2.1 Global Separation Systems for Commercial Biotechnology Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Separation Systems for Commercial Biotechnology Sales Value, by Application (2019-2030)
4.2.3 Global Separation Systems for Commercial Biotechnology Sales Value, by Application (%) (2019-2030)
4.3 Global Separation Systems for Commercial Biotechnology Sales Volume by Application
4.3.1 Global Separation Systems for Commercial Biotechnology Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Separation Systems for Commercial Biotechnology Sales Volume, by Application (2019-2030)
4.3.3 Global Separation Systems for Commercial Biotechnology Sales Volume, by Application (%) (2019-2030)
4.4 Global Separation Systems for Commercial Biotechnology Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Separation Systems for Commercial Biotechnology Sales Value by Region
5.1.1 Global Separation Systems for Commercial Biotechnology Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Separation Systems for Commercial Biotechnology Sales Value by Region (2019-2024)
5.1.3 Global Separation Systems for Commercial Biotechnology Sales Value by Region (2025-2030)
5.1.4 Global Separation Systems for Commercial Biotechnology Sales Value by Region (%), (2019-2030)
5.2 Global Separation Systems for Commercial Biotechnology Sales Volume by Region
5.2.1 Global Separation Systems for Commercial Biotechnology Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Separation Systems for Commercial Biotechnology Sales Volume by Region (2019-2024)
5.2.3 Global Separation Systems for Commercial Biotechnology Sales Volume by Region (2025-2030)
5.2.4 Global Separation Systems for Commercial Biotechnology Sales Volume by Region (%), (2019-2030)
5.3 Global Separation Systems for Commercial Biotechnology Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Separation Systems for Commercial Biotechnology Sales Value, 2019-2030
5.4.2 North America Separation Systems for Commercial Biotechnology Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Separation Systems for Commercial Biotechnology Sales Value, 2019-2030
5.5.2 Europe Separation Systems for Commercial Biotechnology Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Separation Systems for Commercial Biotechnology Sales Value, 2019-2030
5.6.2 Asia Pacific Separation Systems for Commercial Biotechnology Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Separation Systems for Commercial Biotechnology Sales Value, 2019-2030
5.7.2 South America Separation Systems for Commercial Biotechnology Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Separation Systems for Commercial Biotechnology Sales Value, 2019-2030
5.8.2 Middle East & Africa Separation Systems for Commercial Biotechnology Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Separation Systems for Commercial Biotechnology Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Separation Systems for Commercial Biotechnology Sales Value
6.2.1 Key Countries/Regions Separation Systems for Commercial Biotechnology Sales Value, 2019-2030
6.2.2 Key Countries/Regions Separation Systems for Commercial Biotechnology Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Separation Systems for Commercial Biotechnology Sales Value, 2019-2030
6.3.2 United States Separation Systems for Commercial Biotechnology Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Separation Systems for Commercial Biotechnology Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Separation Systems for Commercial Biotechnology Sales Value, 2019-2030
6.4.2 Europe Separation Systems for Commercial Biotechnology Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Separation Systems for Commercial Biotechnology Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Separation Systems for Commercial Biotechnology Sales Value, 2019-2030
6.5.2 China Separation Systems for Commercial Biotechnology Sales Value by Type (%), 2023 VS 2030
6.5.3 China Separation Systems for Commercial Biotechnology Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Separation Systems for Commercial Biotechnology Sales Value, 2019-2030
6.6.2 Japan Separation Systems for Commercial Biotechnology Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Separation Systems for Commercial Biotechnology Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Separation Systems for Commercial Biotechnology Sales Value, 2019-2030
6.7.2 South Korea Separation Systems for Commercial Biotechnology Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Separation Systems for Commercial Biotechnology Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Separation Systems for Commercial Biotechnology Sales Value, 2019-2030
6.8.2 Southeast Asia Separation Systems for Commercial Biotechnology Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Separation Systems for Commercial Biotechnology Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Separation Systems for Commercial Biotechnology Sales Value, 2019-2030
6.9.2 India Separation Systems for Commercial Biotechnology Sales Value by Type (%), 2023 VS 2030
6.9.3 India Separation Systems for Commercial Biotechnology Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Thermo Fisher Scientific
7.1.1 Thermo Fisher Scientific Company Information
7.1.2 Thermo Fisher Scientific Introduction and Business Overview
7.1.3 Thermo Fisher Scientific Separation Systems for Commercial Biotechnology Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Thermo Fisher Scientific Separation Systems for Commercial Biotechnology Product Offerings
7.1.5 Thermo Fisher Scientific Recent Development
7.2 GE Healthcare
7.2.1 GE Healthcare Company Information
7.2.2 GE Healthcare Introduction and Business Overview
7.2.3 GE Healthcare Separation Systems for Commercial Biotechnology Sales, Revenue and Gross Margin (2019-2024)
7.2.4 GE Healthcare Separation Systems for Commercial Biotechnology Product Offerings
7.2.5 GE Healthcare Recent Development
7.3 Agilent Technologies;Shimadzu Corporation
7.3.1 Agilent Technologies;Shimadzu Corporation Company Information
7.3.2 Agilent Technologies;Shimadzu Corporation Introduction and Business Overview
7.3.3 Agilent Technologies;Shimadzu Corporation Separation Systems for Commercial Biotechnology Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Agilent Technologies;Shimadzu Corporation Separation Systems for Commercial Biotechnology Product Offerings
7.3.5 Agilent Technologies;Shimadzu Corporation Recent Development
7.4 µþ¾±´Ç²Ñé°ù¾±±ð³Ü³æ
7.4.1 µþ¾±´Ç²Ñé°ù¾±±ð³Ü³æ Company Information
7.4.2 µþ¾±´Ç²Ñé°ù¾±±ð³Ü³æ Introduction and Business Overview
7.4.3 µþ¾±´Ç²Ñé°ù¾±±ð³Ü³æ Separation Systems for Commercial Biotechnology Sales, Revenue and Gross Margin (2019-2024)
7.4.4 µþ¾±´Ç²Ñé°ù¾±±ð³Ü³æ Separation Systems for Commercial Biotechnology Product Offerings
7.4.5 µþ¾±´Ç²Ñé°ù¾±±ð³Ü³æ Recent Development
7.5 Bio-Rad Laboratories, Inc.
7.5.1 Bio-Rad Laboratories, Inc. Company Information
7.5.2 Bio-Rad Laboratories, Inc. Introduction and Business Overview
7.5.3 Bio-Rad Laboratories, Inc. Separation Systems for Commercial Biotechnology Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Bio-Rad Laboratories, Inc. Separation Systems for Commercial Biotechnology Product Offerings
7.5.5 Bio-Rad Laboratories, Inc. Recent Development
7.6 Hitachi Koki
7.6.1 Hitachi Koki Company Information
7.6.2 Hitachi Koki Introduction and Business Overview
7.6.3 Hitachi Koki Separation Systems for Commercial Biotechnology Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Hitachi Koki Separation Systems for Commercial Biotechnology Product Offerings
7.6.5 Hitachi Koki Recent Development
7.7 Merck &, Inc.
7.7.1 Merck &, Inc. Company Information
7.7.2 Merck &, Inc. Introduction and Business Overview
7.7.3 Merck &, Inc. Separation Systems for Commercial Biotechnology Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Merck &, Inc. Separation Systems for Commercial Biotechnology Product Offerings
7.7.5 Merck &, Inc. Recent Development
7.8 QIAGEN
7.8.1 QIAGEN Company Information
7.8.2 QIAGEN Introduction and Business Overview
7.8.3 QIAGEN Separation Systems for Commercial Biotechnology Sales, Revenue and Gross Margin (2019-2024)
7.8.4 QIAGEN Separation Systems for Commercial Biotechnology Product Offerings
7.8.5 QIAGEN Recent Development
7.9 Waters Corp
7.9.1 Waters Corp Company Information
7.9.2 Waters Corp Introduction and Business Overview
7.9.3 Waters Corp Separation Systems for Commercial Biotechnology Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Waters Corp Separation Systems for Commercial Biotechnology Product Offerings
7.9.5 Waters Corp Recent Development
7.10 Sartorius
7.10.1 Sartorius Company Information
7.10.2 Sartorius Introduction and Business Overview
7.10.3 Sartorius Separation Systems for Commercial Biotechnology Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Sartorius Separation Systems for Commercial Biotechnology Product Offerings
7.10.5 Sartorius Recent Development
7.11 PerkinElmer, Inc.
7.11.1 PerkinElmer, Inc. Company Information
7.11.2 PerkinElmer, Inc. Introduction and Business Overview
7.11.3 PerkinElmer, Inc. Separation Systems for Commercial Biotechnology Sales, Revenue and Gross Margin (2019-2024)
7.11.4 PerkinElmer, Inc. Separation Systems for Commercial Biotechnology Product Offerings
7.11.5 PerkinElmer, Inc. Recent Development
7.12 Danaher
7.12.1 Danaher Company Information
7.12.2 Danaher Introduction and Business Overview
7.12.3 Danaher Separation Systems for Commercial Biotechnology Sales, Revenue and Gross Margin (2019-2024)
7.12.4 Danaher Separation Systems for Commercial Biotechnology Product Offerings
7.12.5 Danaher Recent Development
7.13 Miltenyi Biotec
7.13.1 Miltenyi Biotec Company Information
7.13.2 Miltenyi Biotec Introduction and Business Overview
7.13.3 Miltenyi Biotec Separation Systems for Commercial Biotechnology Sales, Revenue and Gross Margin (2019-2024)
7.13.4 Miltenyi Biotec Separation Systems for Commercial Biotechnology Product Offerings
7.13.5 Miltenyi Biotec Recent Development
7.14 BD
7.14.1 BD Company Information
7.14.2 BD Introduction and Business Overview
7.14.3 BD Separation Systems for Commercial Biotechnology Sales, Revenue and Gross Margin (2019-2024)
7.14.4 BD Separation Systems for Commercial Biotechnology Product Offerings
7.14.5 BD Recent Development
8 Industry Chain Analysis
8.1 Separation Systems for Commercial Biotechnology Industrial Chain
8.2 Separation Systems for Commercial Biotechnology Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Separation Systems for Commercial Biotechnology Sales Model
8.5.2 Sales Channel
8.5.3 Separation Systems for Commercial Biotechnology Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
Thermo Fisher Scientific
GE Healthcare
Agilent Technologies;Shimadzu Corporation
µþ¾±´Ç²Ñé°ù¾±±ð³Ü³æ
Bio-Rad Laboratories, Inc.
Hitachi Koki
Merck &, Inc.
QIAGEN
Waters Corp
Sartorius
PerkinElmer, Inc.
Danaher
Miltenyi Biotec
BD
Ìý
Ìý
*If Applicable.
